A predictive model of fear of cancer recurrence for patients undergoing chemotherapy

Se Jin Hong, Nah Mee Shin, Sunyoung Jung

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

Purpose: A number of cancer patients experience fear of cancer recurrence (FCR), which affects their psychological adjustment. This study tested the hypothesized model of FCR to predict psychological adjustment in cancer patients undergoing chemotherapy. Methods: A total of 203 patients, who had been diagnosed with either breast cancer or colorectal cancer and were undergoing chemotherapy, were recruited from two university hospitals in Seoul, Korea. Data were collected using validated questionnaires and were analyzed using SPSS 24.0 and AMOS 25.0 program for structural equation modeling procedures. Results: The fit index of the hypothesized model was appropriate. Symptom distress, contextual factors, FCR, and illness representations had statistically significant direct, indirect, and total effects on psychological adjustment. These variables explained 76% of the total variance of the psychological adjustment in cancer patients undergoing chemotherapy. Fear of cancer recurrence was a mediating factor for the effects of symptom distress, contextual factors, and illness representation on psychological adjustment. Conclusions: Based on these results, interventions aimed at reducing symptom distress and FCR, and improving social support, optimism, and illness representations, may be useful for the successful psychological adjustment of cancer patients undergoing chemotherapy.

Original languageEnglish
Pages (from-to)4173-4181
Number of pages9
JournalSupportive Care in Cancer
Volume28
Issue number9
DOIs
Publication statusPublished - 2020 Sept 1

Keywords

  • Cancer patients
  • Chemotherapy
  • Fear of cancer recurrence
  • Psychological adjustment
  • Symptom distress

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'A predictive model of fear of cancer recurrence for patients undergoing chemotherapy'. Together they form a unique fingerprint.

Cite this